awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36554279-05C90ECF-C82B-4F2A-B2B5-23B3766F90DD
Q36554279-05C90ECF-C82B-4F2A-B2B5-23B3766F90DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36554279-05C90ECF-C82B-4F2A-B2B5-23B3766F90DD
Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study.
P2860
Q36554279-05C90ECF-C82B-4F2A-B2B5-23B3766F90DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36554279-05C90ECF-C82B-4F2A-B2B5-23B3766F90DD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
baf931120d244b700b97940e926a6c7133fd8f0b
P2860
Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring.